Biology of stem and myeloid progenitor cells in myelodysplastic syndromes.
作者信息
Span L F, de Witte T M
机构信息
Department of Hematology, University Medical Center Nijmegen, Nijmegen, The Netherlands.
出版信息
Cancer Treat Res. 2001;108:45-63. doi: 10.1007/978-1-4615-1463-3_3.
PMID:11702605
Abstract
摘要
相似文献
1
Biology of stem and myeloid progenitor cells in myelodysplastic syndromes.
Cancer Treat Res. 2001;108:45-63. doi: 10.1007/978-1-4615-1463-3_3.
2
Apoptosis in MDS: a new perspective.
Cancer Treat Res. 2001;108:101-9. doi: 10.1007/978-1-4615-1463-3_7.
3
Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway.
Blood. 2001 May 15;97(10):3011-6. doi: 10.1182/blood.v97.10.3011.
4
Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Leukemia. 1997 Jun;11(6):839-45. doi: 10.1038/sj.leu.2400654.
5
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Blood. 2002 Dec 15;100(13):4427-32. doi: 10.1182/blood-2002-01-0096. Epub 2002 Aug 15.
6
Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome.
Blood. 1996 Aug 1;88(3):1122-3.
7
Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Cancer Treat Res. 2001;108:185-230.
8
[Myelodysplastic syndromes].
Rev Invest Clin. 1997 May;49 Suppl 1:15-21.
9
CD34 immunophenotyping of blasts in myelodysplasia.
Leuk Lymphoma. 1994 Sep;15(1-2):65-9. doi: 10.3109/10428199409051679.
10
Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
Br J Haematol. 2004 Sep;126(6):806-14. doi: 10.1111/j.1365-2141.2004.05132.x.
Zotero 插件